Einloggen

Thematische Bibliographien / United States. Advisory Committee on Immunization Practices / Zeitschriftenartikel

Zeitschriftenartikel zum Thema „United States. Advisory Committee on Immunization Practices“

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: United States. Advisory Committee on Immunization Practices.

Autor: Grafiati

Veröffentlicht am 25. Juli 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "United States. Advisory Committee on Immunization Practices" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

O’Leary, Sean T., Yvonne A. Maldonado und David W. Kimberlin. „Update from the Advisory Committee on Immunization Practices“. Journal of the Pediatric Infectious Diseases Society 9, Nr. 1 (04.02.2020): 3–5. http://dx.doi.org/10.1093/jpids/piaa008.

Der volle Inhalt der Quelle

Annotation:

Abstract The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, meets 3 times per year to develop recommendations for vaccine use in the United States. There are usually 15 voting members; members’ terms are for 4 years. ACIP members and Centers for Disease Control and Prevention staff discuss the epidemiology of vaccine-preventable diseases and vaccine research, effectiveness, safety data, and results from clinical trials. Representatives from the American Academy of Pediatrics (Y. A. M., D. W. K.) and the Pediatric Infectious Diseases Society (S. T. O.) are present as liaisons to the ACIP. The ACIP met on 23–24 October 2019 to discuss pertussis vaccines, the child/adolescent and adult immunization schedule, influenza vaccine effectiveness and safety, Ebola vaccine, orthopoxvirus vaccines, Dengue vaccine, rabies vaccine, measles, and vaccine safety update.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Hall, Caroline Breese. „The Recommended Childhood Immunization Schedule of the United States“. Pediatrics 95, Nr. 1 (01.01.1995): 135–37. http://dx.doi.org/10.1542/peds.95.1.135.

Der volle Inhalt der Quelle

Annotation:

The complexity of our current schedule for routine immunization of children is expanding and experienced by both physician and parent. Over nearly two decades in the 1970s and 1980s only one new vaccine was added to the routine immunization for children. However, in the last few years since 1989, the schedule routinely recommended for children has been augmented by eight to ten new doses or vaccines. The confusion has been compounded by differences in the schedules developed by the American Academy of Pediatrics' (AAP) Committee on Infectious Diseases and that of the Centers for Disease Control Advisory Committee on Immunization Practices (ACIP).

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

O’Leary, Sean T., Yvonne A. Maldonado und David W. Kimberlin. „Update From the Advisory Committee on Immunization Practices“. Journal of the Pediatric Infectious Diseases Society 8, Nr. 5 (01.08.2019): 379–83. http://dx.doi.org/10.1093/jpids/piz045.

Der volle Inhalt der Quelle

Annotation:

Abstract The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, meets 3 times per year to develop recommendations for vaccine use in the United States. The group usually has 15 voting members, each of whom is appointed to a 4-year term. ACIP members and Centers for Disease Control and Prevention staff discuss the epidemiology of vaccine-preventable diseases and vaccine research, effectiveness, safety data, and clinical trial results. Representatives from the American Academy of Pediatrics (Y. A. M. and D. W. K.) and the Pediatric Infectious Diseases Society (S. T. O.) are present as liaisons to the ACIP. The ACIP met February 27 to 28, 2019, to discuss hepatitis A (HepA) vaccination of human immunodeficiency virus–infected persons, pneumococcal vaccination among adults aged 65 years or older, influenza vaccine effectiveness and safety, anthrax vaccination in the setting of a mass exposure, human papillomavirus vaccine, zoster vaccines, and Japanese encephalitis vaccine.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

O’leary, Sean T., Yvonne A. Maldonado und David W. Kimberlin. „Update From the Advisory Committee on Immunization Practices“. Journal of the Pediatric Infectious Diseases Society 8, Nr. 6 (07.10.2019): 495–500. http://dx.doi.org/10.1093/jpids/piz058.

Der volle Inhalt der Quelle

Annotation:

Abstract The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, meets 3 times per year to develop recommendations for vaccine use in the United States. There usually are 15 voting members, but at the June 2019 meeting, only 14 were present; each member’s term is 4 years. ACIP members and Centers for Disease Control and Prevention (CDC) staff discuss the epidemiology of vaccine-preventable diseases and vaccine research, effectiveness, safety data, and clinical trial results. Representatives from the American Academy of Pediatrics (AAP) (Y. A. M. and D. W. K.) and the Pediatric Infectious Diseases Society (S. T. O.) are present as liaisons to the ACIP. The ACIP met on June 26 to 27, 2019, to discuss the use of human papillomavirus (HPV) vaccine in adults, pneumococcal vaccines in adults, measles updates, zoster vaccine, influenza vaccines, hepatitis A virus (HAV) vaccines, meningococcal vaccines, and dengue vaccine.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Walton, L. Reed, Walter A. Orenstein und Larry K. Pickering. „The history of the United States Advisory Committee on Immunization Practices (ACIP)“. Vaccine 33, Nr. 3 (Januar 2015): 405–14. http://dx.doi.org/10.1016/j.vaccine.2014.09.043.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Pau, Alice K., Ian R. McNicholl und Kenneth J. Pursell. „Active Immunization in HIV‐infected Patients“. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16, Nr. 2 (04.03.1996): 163–70. http://dx.doi.org/10.1002/j.1875-9114.1996.tb02934.x.

Der volle Inhalt der Quelle

Annotation:

Patients infected with human immunodeficiency virus (HIV) are at risk for various viral and bacterial infections. Active immunization with currently available vaccines may reduce the risk of some vaccine‐preventable diseases in this population. Based on available data, most vaccines used in the United States are safe in HIV‐infected adults and children. Their clinical efficacy in these individuals is not well defined, although it appears that patients in the earlier stages of infection are more likely to mount a protective antibody response than those in the later stages. Current guidelines for vaccination in HIV‐infected children and adults in the United States have been recommended by the Advisory Committee on Immunization Practices.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Paz-Bailey, Gabriela, Laura Adams, Joshua M. Wong, Katherine A. Poehling, Wilbur H. Chen, Veronica McNally, Robert L. Atmar und Stephen H. Waterman. „Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021“. MMWR. Recommendations and Reports 70, Nr. 6 (17.12.2021): 1–16. http://dx.doi.org/10.15585/mmwr.rr7006a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Mbaeyi, Sarah A., Catherine H. Bozio, Jonathan Duffy, Lorry G. Rubin, Susan Hariri, David S. Stephens und Jessica R. MacNeil. „Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020“. MMWR. Recommendations and Reports 69, Nr. 9 (25.09.2020): 1–41. http://dx.doi.org/10.15585/mmwr.rr6909a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Smith, Jean C. „Immunization Policy Development in the United States: The Role of the Advisory Committee on Immunization Practices“. Annals of Internal Medicine 150, Nr. 1 (06.01.2009): 45. http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00009.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Foster, Stephan L., und Michael D. Hogue. „Advisory Committee on Immunization Practices: Working to Improve Vaccine Use in the United States“. Journal of the American Pharmacists Association 45, Nr. 3 (Mai 2005): 408–11. http://dx.doi.org/10.1331/1544345054003831.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Gopal, Srirupa, Kathryn Edwards, Buddy Creech und Joern-Hendrik Weitkamp. „Variability in Immunization Practices for Preterm Infants“. American Journal of Perinatology 35, Nr. 14 (08.06.2018): 1394–98. http://dx.doi.org/10.1055/s-0038-1660453.

Der volle Inhalt der Quelle

Annotation:

Introduction The Advisory Committee on Immunization Practices and the American Academy of Pediatrics (AAP) recommend the same immunization schedule for preterm and term infants. However, significant delays in vaccination of premature infants have been reported. Objective The objective of this study was to assess the variability of immunization practices in preterm infants. Study Design We conducted an online survey of 2,443 neonatologists in the United States, who are members of the Section for Neonatal-Perinatal Medicine of the AAP. Questions were targeted at immunization practices in the neonatal intensive care unit (NICU). Results Of the 420 responses (17%) received, 55% of providers administer the first vaccine at >2-month chronological age. Most providers (83%) surveyed reported delaying vaccines in the setting of clinical illness. Sixty percent reported increasing frequency of apnea–bradycardia events following immunization. More than half administer the initial vaccines over several days despite lack of supporting data. Reported considerations in delaying or spreading out 2-month vaccines were clinical instability, provider preference, lower gestational age, and lower birth weight. Conclusion This survey substantiates the variability of immunizations practices in the NICU and identifies reasons for this variability. Future studies should inform better practice guidance for immunization of preterm NICU patients based on vaccine safety and effectiveness.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Judelsohn, Richard. „Changing the US Polio Immunization Schedule Would Be Bad Public Health Policy“. Pediatrics 98, Nr. 1 (01.07.1996): 115–16. http://dx.doi.org/10.1542/peds.98.1.115.

Der volle Inhalt der Quelle

Annotation:

Last October, a 10-member advisory committee to the United States (US) Centers for Disease Control and Prevention (CDC) voted to change the US government's well-established polio immunization policy. The current polio immunization schedule, consisting of a regimen of four doses of oral poliovaccine (OPV), is widely credited with effectively eradicating polio in the US and the western hemisphere. In fact, the last naturally occurring case of polio occurred in the US in 1979 and in the western hemisphere in 1991. Because OPV contains a live but weakened virus, it has, on very rare occasions, been associated with paralytic polio. In the hope of preventing some of the 8 to 10 cases of vaccine-associated paralytic poliomyelitis (VAPP) diagnosed each year, the CDC's Advisory Committee on Immunization Practices (ACIP) has recommended a combined immunization schedule of two doses of inactivated polio virus (IPV), which is delivered by injection, followed by two doses of OPV.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Wood, D. L., und P. A. Brunell. „Measles control in the United States: problems of the past and challenges for the future.“ Clinical Microbiology Reviews 8, Nr. 2 (April 1995): 260–67. http://dx.doi.org/10.1128/cmr.8.2.260.

Der volle Inhalt der Quelle

Annotation:

Elimination of indigenous measles from the United States has been a public priority since 1978. To assess the progress made toward this goal, we review the epidemiology of measles from 1963 to the present. From the 1970s through early into the recent measles epidemic, the majority of measles cases were in highly vaccinated, school-age children. This was due primarily to a 1 to 5% primary measles-mumps-rubella vaccine failure rate and nonrandom mixing patterns among school-age populations. To eliminate susceptible individuals in the school-age populations, a second dose of measles vaccine is now recommended between 5 and 6 years or 11 and 12 years by both the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Later in the epidemic, measles cases surged among unimmunized preschool children, especially among the poor in inner-city areas. Immunization rates have been documented to be low among preschool populations because of missed opportunities to administer vaccines at all health visits and barriers to access to immunizations. To raise immunization rates, the age for the first measles-mumps-rubella immunization was lowered to 12 to 15 months of age, federal immunization funding has increased, and new standards for immunization delivery have been developed and promulgated.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Choi, Mary J., Caitlin M. Cossaboom, Amy N. Whitesell, Jonathan W. Dyal, Allison Joyce, Rebecca L. Morgan, Doug Campos-Outcalt et al. „Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020“. MMWR. Recommendations and Reports 70, Nr. 1 (08.01.2021): 1–12. http://dx.doi.org/10.15585/mmwr.rr.7001a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Choi, Mary J., Caitlin M. Cossaboom, Amy N. Whitesell, Jonathan W. Dyal, Allison Joyce, Rebecca L. Morgan, Doug Campos-Outcalt et al. „Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020“. MMWR. Recommendations and Reports 70, Nr. 1 (08.01.2021): 1–12. http://dx.doi.org/10.15585/mmwr.rr7001a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Hills, Susan L., Katherine A. Poehling, Wilbur H. Chen und J. Erin Staples. „Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023“. MMWR. Recommendations and Reports 72, Nr. 5 (10.11.2023): 1–29. http://dx.doi.org/10.15585/mmwr.rr7205a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Freedman, Mark S., Kevin Ault und Henry Bernstein. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021“. MMWR. Morbidity and Mortality Weekly Report 70, Nr. 6 (12.02.2021): 193–96. http://dx.doi.org/10.15585/mmwr.mm7006a2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Bridges, Carolyn B., und Tamera Coyne-Beasley. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2014*“. Annals of Internal Medicine 160, Nr. 3 (04.02.2014): 190–97. http://dx.doi.org/10.7326/m13-2826.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Kim, David K., Carolyn B. Bridges und Kathleen H. Harriman. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2015*“. Annals of Internal Medicine 162, Nr. 3 (03.02.2015): 214. http://dx.doi.org/10.7326/m14-2755.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Kim, David K., Carolyn B. Bridges und Kathleen H. Harriman. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2016*“. Annals of Internal Medicine 164, Nr. 3 (02.02.2016): 184. http://dx.doi.org/10.7326/m15-3005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Murthy, Neil, A. Patricia Wodi, Henry Bernstein, Veronica McNally, Sybil Cineas und Kevin Ault. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022“. MMWR. Morbidity and Mortality Weekly Report 71, Nr. 7 (18.02.2022): 229–33. http://dx.doi.org/10.15585/mmwr.mm7107a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Robinson, Candice L. „Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016“. MMWR. Morbidity and Mortality Weekly Report 65, Nr. 4 (05.02.2016): 86–87. http://dx.doi.org/10.15585/mmwr.mm6504a4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Robinson, Candice L., und ACIP Child. „Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016“. MMWR. Morbidity and Mortality Weekly Report 65, Nr. 4 (02.02.2016): 1–2. http://dx.doi.org/10.15585/mmwr.mm6504a4er.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Kim, David K., Carolyn B. Bridges und Kathleen H. Harriman. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016“. MMWR. Morbidity and Mortality Weekly Report 65, Nr. 4 (05.02.2016): 88–90. http://dx.doi.org/10.15585/mmwr.mm6504a5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Kim, David K., Carolyn B. Bridges und Kathleen H. Harriman. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016“. MMWR. Morbidity and Mortality Weekly Report 65, Nr. 4 (02.02.2016): 1–3. http://dx.doi.org/10.15585/mmwr.mm6504a5er.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Kim, David K., Laura E. Riley, Kathleen H. Harriman, Paul Hunter und Carolyn B. Bridges. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017“. MMWR. Morbidity and Mortality Weekly Report 66, Nr. 5 (10.02.2017): 136–38. http://dx.doi.org/10.15585/mmwr.mm6605e2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Kim, David K., Laura E. Riley und Paul Hunter. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2018“. MMWR. Morbidity and Mortality Weekly Report 67, Nr. 5 (09.02.2018): 158–60. http://dx.doi.org/10.15585/mmwr.mm6705e3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Kim, David K., und Paul Hunter. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019“. MMWR. Morbidity and Mortality Weekly Report 68, Nr. 5 (08.02.2019): 115–18. http://dx.doi.org/10.15585/mmwr.mm6805a5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Freedman, Mark S., Paul Hunter, Kevin Ault und Andrew Kroger. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020“. MMWR. Morbidity and Mortality Weekly Report 69, Nr. 5 (07.02.2020): 133–35. http://dx.doi.org/10.15585/mmwr.mm6905a4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Robinson, C. L. „Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years-United States, 2016“. American Journal of Transplantation 16, Nr. 6 (20.05.2016): 1928–29. http://dx.doi.org/10.1111/ajt.13858.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Kim, D. K., C. B. Bridges und K. H. Harriman. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2016“. American Journal of Transplantation 16, Nr. 6 (20.05.2016): 1930–32. http://dx.doi.org/10.1111/ajt.13877.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Kim, D. K., L. E. Riley, K. H. Harriman, P. Hunter und C. B. Bridges. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2017“. American Journal of Transplantation 17, Nr. 4 (30.03.2017): 1132–35. http://dx.doi.org/10.1111/ajt.14244.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Kim, David K., und Paul Hunter. „Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older — United States, 2019“. American Journal of Transplantation 19, Nr. 4 (25.03.2019): 1232–35. http://dx.doi.org/10.1111/ajt.15336.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Murthy, Neil, A. Patricia Wodi, Veronica McNally, Sybil Cineas und Kevin Ault. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023“. MMWR. Morbidity and Mortality Weekly Report 72, Nr. 6 (10.02.2023): 141–44. http://dx.doi.org/10.15585/mmwr.mm7206a2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Murthy, Neil, A. Patricia Wodi, Veronica V. McNally, Matthew F. Daley und Sybil Cineas. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024“. MMWR. Morbidity and Mortality Weekly Report 73, Nr. 1 (11.01.2024): 11–15. http://dx.doi.org/10.15585/mmwr.mm7301a3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Krow-Lucal, Elisabeth, Mona Marin, Leah Shepersky, Lynn Bahta, Jamie Loehr und Kathleen Dooling. „Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022“. MMWR. Morbidity and Mortality Weekly Report 71, Nr. 46 (18.11.2022): 1465–70. http://dx.doi.org/10.15585/mmwr.mm7146a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Bednarczyk, Robert A., Mallory K. Ellingson und Saad B. Omer. „Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data“. Journal of Infectious Diseases 220, Nr. 5 (17.01.2019): 730–34. http://dx.doi.org/10.1093/infdis/jiy682.

Der volle Inhalt der Quelle

Annotation:

Abstract Human papillomavirus (HPV) vaccination is suboptimally used in the United States. Vaccination before the 13th birthday is recommended by the Advisory Committee on Immunization Practices and vaccination before the 15th birthday requires only 2 doses. We estimated the proportion of adolescents up to date for HPV vaccine using provider-verified vaccination data from the 2016 National Immunization Survey-Teen. Only 16% of US adolescents completed HPV vaccination before turning 13, and 35% completed HPV vaccination before turning 15. With sexual activity initiation increasing throughout adolescence and higher immunogenicity for younger vaccinees, vaccination before the 13th birthday can provide better protection against HPV-related cancers.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

CHIRICO, GAETANO, CESARE BELLONI, ANTONELLA GASPARONI, ROSA MARIA CERBO, GIORGIO RONDINI, CATHERINE KLERSY, PAOLO ORSOLINI und GAETANO FILICE. „Hepatitis B Immunization in Infants of Hepatitis B Surface Antigen-Negative Mothers“. Pediatrics 92, Nr. 5 (01.11.1993): 717–19. http://dx.doi.org/10.1542/peds.92.5.717.

Der volle Inhalt der Quelle

Annotation:

The American Academy of Pediatrics (AAP) Committee on Infectious Diseases and the Immunization Practices Advisory Committee of the Centers for Disease Control have recently pointed out that the selective strategy of immunization against hepatitis B virus (HBV) of high-risk populations has not resulted in the limitation of the diffusion of the disease. In fact, in spite of vaccine availability for more than 10 years, about 200 000 to 300 000 new cases of infection occur in the United States each year. Therefore, the AAP recommended the "universal hepatitis B immunization" strategy as a means to control the disease.1,2 In Italy, where about 400 000 new cases of infection are expected each year, the vaccination has been extended to all newborns, regardless of mother's serologic status (and, for the first 12 years, to all 12-year-old adolescents), with a law promulgated in May 1991.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Wodi, A. Patricia, Kevin Ault, Paul Hunter, Veronica McNally, Peter G. Szilagyi und Henry Bernstein. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2021“. MMWR. Morbidity and Mortality Weekly Report 70, Nr. 6 (12.02.2021): 189–92. http://dx.doi.org/10.15585/mmwr.mm7006a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Wodi, A. Patricia, Neil Murthy, Henry Bernstein, Veronica McNally, Sybil Cineas und Kevin Ault. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022“. MMWR. Morbidity and Mortality Weekly Report 71, Nr. 7 (18.02.2022): 234–37. http://dx.doi.org/10.15585/mmwr.mm7107a2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Robinson, Candice L., José R. Romero, Allison Kempe und Cynthia Pellegrini. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017“. MMWR. Morbidity and Mortality Weekly Report 66, Nr. 5 (10.02.2017): 134–35. http://dx.doi.org/10.15585/mmwr.mm6605e1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Robinson, Candice L., José R. Romero, Allison Kempe, Cynthia Pellegrini und Peter Szilagyi. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2018“. MMWR. Morbidity and Mortality Weekly Report 67, Nr. 5 (09.02.2018): 156–57. http://dx.doi.org/10.15585/mmwr.mm6705e2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Robinson, Candice L., Henry Bernstein, José R. Romero und Peter Szilagyi. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019“. MMWR. Morbidity and Mortality Weekly Report 68, Nr. 5 (08.02.2019): 112–14. http://dx.doi.org/10.15585/mmwr.mm6805a4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Robinson, Candice L., Henry Bernstein, Katherine Poehling, José R. Romero und Peter Szilagyi. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020“. MMWR. Morbidity and Mortality Weekly Report 69, Nr. 5 (07.02.2020): 130–32. http://dx.doi.org/10.15585/mmwr.mm6905a3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Robinson, C. L., J. R. Romero, A. Kempe und C. Pellegrini. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2017“. American Journal of Transplantation 17, Nr. 4 (30.03.2017): 1136–38. http://dx.doi.org/10.1111/ajt.14245.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Robinson, Candice L., Henry Bernstein, José R. Romero und Peter Szilagyi. „Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger — United States, 2019“. American Journal of Transplantation 19, Nr. 4 (25.03.2019): 1229–31. http://dx.doi.org/10.1111/ajt.15335.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Wodi, A. Patricia, Neil Murthy, Veronica McNally, Sybil Cineas und Kevin Ault. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023“. MMWR. Morbidity and Mortality Weekly Report 72, Nr. 6 (10.02.2023): 137–40. http://dx.doi.org/10.15585/mmwr.mm7206a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Wodi, A. Patricia, Neil Murthy, Veronica V. McNally, Matthew F. Daley und Sybil Cineas. „Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024“. MMWR. Morbidity and Mortality Weekly Report 73, Nr. 1 (11.01.2024): 6–10. http://dx.doi.org/10.15585/mmwr.mm7301a2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Bower, William A., Jarad Schiffer, Robert L. Atmar, Wendy A. Keitel, Arthur M. Friedlander, Lindy Liu, Yon Yu, David S. Stephens, Conrad P. Quinn und Katherine Hendricks. „Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019“. MMWR. Recommendations and Reports 68, Nr. 4 (13.12.2019): 1–14. http://dx.doi.org/10.15585/mmwr.rr6804a1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Pike, Jamison, Andrew J. Leidner, Jessica R. MacNeil und Amanda C. Cohn. „Review of the economic evidence presented to the United States Advisory Committee on Immunization Practices, 2012–2016“. Vaccine 37, Nr. 1 (Januar 2019): 7–10. http://dx.doi.org/10.1016/j.vaccine.2018.11.055.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!